Stroke telepresence
Removing all geographic barriers
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Telestroke permits time-sensitive acute stroke consultations to remote Emergency Departments (ED) regardless of distance.1 Time is the critical issue in acute stroke, where minutes matter. The odds of an excellent 3-month outcome decline with every minute before tissue plasminogen activator (tPA) is administered.2 In this issue of Neurology®, Sairanen and colleagues3 describe how “hub” consultants provided telestroke coverage to remote Finnish “spoke” hospitals 80–500 miles away, to help decide whether to administer tPA. They showed that the 3-month functional outcomes and symptomatic intracranial bleeding rate in tPA-treated spoke patients were similar to those treated in person at the hub.
More than half of spoke consultations resulted in the administration of IV tPA, a higher percentage than observed in other studies, where only about a quarter are treated.4 This may be due to “spot coverage.” The 29 consultants provided less than 24-hour coverage; during the regular day shift, tPA was administered by local neurologists so that the ED staff was experienced. It is likely, then, that experienced ED teams' consultations were more likely to result in tPA administration. The consultations took about 23 minutes and the median onset to treatment time was about 120 minutes, further evidence that telestroke consultations lead to early treatment.4 All patients remained in the spoke hospitals …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Dennis Bourdette and Dr. Lindsey Wooliscroft
► Watch
Alert Me
Recommended articles
-
Articles
IV tissue plasminogen activator use in acute strokeExperience from a statewide registryY. Z. Deng, M. J. Reeves, B. S. Jacobs et al.Neurology, February 13, 2006 -
Article
Emerging temporal trends in tissue plasminogen activator useResults from the BASIC projectJoseph S. Domino, Jonggyu Baek, William J. Meurer et al.Neurology, October 21, 2016 -
Article
Clinical and Neuroimaging Outcomes of Direct Thrombectomy vs Bridging Therapy in Large Vessel OcclusionAnalysis of the SELECT Cohort StudyAmrou Sarraj, James Grotta, Gregory W. Albers et al.Neurology, April 19, 2021 -
Article
Reliability of brain CT evaluation by stroke neurologists in telemedicineVolker Puetz, Ulf Bodechtel, Johannes C. Gerber et al.Neurology, December 19, 2012